From BTN
UNLISTED Melbourne biotech AdAlta has signed an agreement with Cellestis R&D, a subsidiary of ASX-listed Cellestis, to identify peptides for a Cellestis diagnostic target.
http://www.biotechnologynews.net/StoryView.asp?StoryID=1033334
regards
Bigtosky